Study finds ovarian cancer-treated women less likely to develop breast cancer
Combined, ovarian and breast cancer affect over 60,000 women in the UK every year
Read More
Tag: Manchester University NHS Foundation Trust
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
